Patents by Inventor Inderdeep Bhatia

Inderdeep Bhatia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bulk polyethylene glycol compositions
    Patent number: 11793876
    Abstract: The present invention relates to bulk dry compositions comprising polyethylene glycol and an additive, such as a flavoring agent and/or sweetener, wherein the additive remains at a consistent concentration throughout the bulk composition. The invention also relates to processes for preparing the bulk dry compositions comprising polyethylene glycol.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: October 24, 2023
    Assignee: L. PERRIGO COMPANY
    Inventors: Lisa Kay Lupton, Kiran Kumar Muppireddy, Inderdeep Bhatia, Carlos O. Paz, Bruce D. Johnson
  • BULK POLYETHYLENE GLYCOL COMPOSITIONS
    Publication number: 20210113698
    Abstract: The present invention relates to bulk dry compositions comprising polyethylene glycol and an additive, such as a flavoring agent and/or sweetener, wherein the additive remains at a consistent concentration throughout the bulk composition. The invention also relates to processes for preparing the bulk dry compositions comprising polyethylene glycol.
    Type: Application
    Filed: October 16, 2020
    Publication date: April 22, 2021
    Inventors: Lisa Kay Lupton, Kiran Kumar Muppireddy, Inderdeep Bhatia, Carlos O. Paz, Bruce D. Johnson
  • Isotretinoin nanoparticulate compositions
    Publication number: 20050129773
    Abstract: The present invention relates to the preparation of a nanoparticulate isotretinoin composition having enhanced bioavailability.
    Type: Application
    Filed: December 6, 2001
    Publication date: June 16, 2005
    Inventors: Inderdeep Bhatia, Rajiv Malik
  • Bioavailable dosage form of isotretinoin
    Patent number: 6740337
    Abstract: The present invention relates to a bioavailable pharmaceutical composition of 13-cis vitamin A acid (also known as 13-cis retinoic acid and isotretinoin) and a process for preparing the same. 13-cis vitamin A acid is a relatively water insoluble compound that degrades when exposed to light and atmospheric oxygen. Due to its instability and relative insolubility, the bioavailability of the drug after oral administration is difficult to achieve and has always been a challenge to a development pharmacist. It would therefore be desirable to provide a dosage form in which the drug is stable and predictably bioavailable.
    Type: Grant
    Filed: April 9, 2001
    Date of Patent: May 25, 2004
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Abha Pant, Inderdeep Bhatia, Sunilendu Bhushan Roy, Rajiv Malik
  • Bioavailable dosage form of isotrentinoin
    Publication number: 20020025338
    Abstract: The present invention relates to a bioavailable pharmaceutical composition of 13-cis vitamin A acid (also known as 13-cis retinoic acid and isotretinoin) and a process for preparing the same. 13-cis vitamin A acid is a relatively water insoluble compound that degrades when exposed to light and atmospheric oxygen. Due to its instability and relative insolubility, the bioavailability of the drug after oral administration is difficult to achieve and has always been a challenge to a development pharmacist. It would therefore be desirable to provide a dosage form in which the drug is stable and predictably bioavailable.
    Type: Application
    Filed: April 9, 2001
    Publication date: February 28, 2002
    Inventors: Abha Pant, Inderdeep Bhatia, Sunilendu Bhushan Roy, Rajiv Malik